Sources of Funding
All research carried out within the Women's Health Research Program in the School of Public Health and Preventive Medicine, Monash University is approved by the Monash University Human Ethics Committee. For studies involving patients attending the Alfred Hospital site, approval is also required from the Human Ethics Committee of the Alfred Hospital. As part of this approval process all sources of funding are clearly stated.
Sources of research funding include:
The main source of funding for the Women's Health Research Program is from the National Health and Medical Research Council (NHMRC) of Australia (NHMRC Project Grants, Prof Susan Davis Principal Research Fellowship, Postdoctoral Fellows and PhD Students), competitive research grants from philanthropic trusts and investigator-initiated studies with industry support.
- The Sex Hormones in Older Women Study is supported by the NHMRC
- The Prevention of Endometrial CAncer with Metformin (PECAM) Study is supported by the NHMRC
- The Sexual Wellbeing After Breast Cancer Study is supported by the National Breast Cancer Foundation.
- Improving the health of Australian Women at Midlife is supported by the Bupa Health Foundation
- The Health of Older Women Study is supported by the International Menopause Society
- The Grollo-Ruzzene Foundation Younger Women’s Health Study is supported by a philanthropic grant from the Grollo-Ruzzene Foundation
- The ATLAS (Adjuvant Tamoxifen Longer Against Shorter) study is funded by the Clinical Trial Services and Epidemiological Studies Unit, Oxford UK.
- The Women After Lung Transplant Study is supported by the Alfred Foundation
- The Women After Breast cancer Follow Up study is supported by Monash Partners
Other sources of support include:
A pharmacokinetic study of testosterone cream was supported by Lawley Pharmaceuticals.
Other financial disclosures: Susan Davis has acted as a consultant to Pfizer and Abbott Pharmaceuticals.